NCT00965536CompletedNot Applicable
A Local Non Interventional Retrospective Register Study of the Current Clinical Treatment Practices and the Number of Hospitalization Days With Seroquel or Seroquel Prolong.
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- AstraZeneca
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- Hospitalisation time
Study Overview
Brief Summary
The general aim of this non interventional study is to clarify what are the current clinical treatment practices of Quetiapine Immediate Release and Quetiapine Extended Release. The primary objectives of the study are:1.To collect information on the used Quetiapine Immediate Release or Quetiapine Extended Release medication 2.To collect information on duration and number of hospitalisation days 3.Change of GAF points
Study Design
- Study Type
- Observational
- Observational Model
- Case Control
- Time Perspective
- Retrospective
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Medication: Seroquel or Seroquel Prolong
- •Diagnosis: F20-F29 or F30-F31 (ICD-10)
- •In-patient
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Hospitalisation time
Time Frame: 2008-2010
Treatment practice
Time Frame: 2008-2010
Secondary Outcomes
- Primary diagnosis(2008-2010)
- Medication at the end of hospitalisation(2008-2010)
- GAF rating points(2008-2010)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
One Year Follow-up of Study 2-79-52030-207 (PRIMARYS) in Acromegalic Patients With MacroadenomaAcromegalyNCT01471405Ipsen54
Active, not recruiting
Not Applicable
The REPLACE Registry for Cholbam® (Cholic Acid)Bile Acid Synthesis DisordersNCT03115086Mirum Pharmaceuticals, Inc.55
Completed
Not Applicable
Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund DatabaseChronic Myeloid LeukaemiaNCT05286528Pfizer1,484
Completed
Not Applicable
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)MPN (Myeloproliferative Neoplasms)NCT02953704Incyte Corporation1,469
Withdrawn
Not Applicable
A Study To Observe Treatment Patterns and Outcomes in Patients With HER2-Positive Unresectable Locally Advanced or Metastatic Breast CancerBreast Cancer, HER2 Positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast CancerNCT02616224Hoffmann-La Roche